U.S. SEC Says It Charges Cassava Sciences, Two Former Executives for Misleading Claims About Alzheimer’s Clinical Trial
美國證券交易委員會稱對cassava sciences及兩位前高管提起訴訟,指控其在關於阿爾茨海默病臨床試驗的聲明中存在誤導性言論
U.S. SEC Says It Charges Cassava Sciences, Two Former Executives for Misleading Claims About Alzheimer’s Clinical Trial
美國證券交易委員會稱對cassava sciences及兩位前高管提起訴訟,指控其在關於阿爾茨海默病臨床試驗的聲明中存在誤導性言論
譯文內容由第三人軟體翻譯。